The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EHA 2016 | How to treat eldery CLL patients
Barbara Eichhorst, MD from University of Cologne, Cologne, Germany discusses the treatment of elderly chronic lymphocytic leukemia (CLL) patients. In the beginning of treatment a geriatric assessment should be undertaken as well as offering support to the patient in the form of psychologists, to help the patients through the treatment phase. Prof Eichhorst also discusses ibrutinib as a treatment option for those patients who cannot tolerate CD20 antibody or who cannot travel to a hematologist and consequently an oral drug would be beneficial. Recorded at the European Hematology Association (EHA) 2016 Annual Congress in Copenhagen, Denmark.
